You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Baxter
McKinsey
Dow
Moodys

Last Updated: April 10, 2020

DrugPatentWatch Database Preview

BIORPHEN Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Biorphen, and what generic alternatives are available?

Biorphen is a drug marketed by Eton Pharms and is included in one NDA.

The generic ingredient in BIORPHEN is phenylephrine hydrochloride. There are twenty-one drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the phenylephrine hydrochloride profile page.

Drug patent expirations by year for BIORPHEN
Drug Prices for BIORPHEN

See drug prices for BIORPHEN

Pharmacology for BIORPHEN
Synonyms for BIORPHEN
.beta.-Dimethylaminoethyl 2-methylbenzhydryl ether
2-(Phenyl-o-tolylmethoxy)ethyldimethylamine
2-Methyldiphenhydramine
4-06-00-04727 (Beilstein Handbook Reference)
83-98-7
AB00053510
AB00053510_20
AB00053510_21
AB00053510-19
API0000039
BDBM50062614
beta-Dimethylaminoethyl 2-methylbenzhydryl ether
beta-Dimethylaminoethyl-2-methylbenzhydryl ether
BPBio1_000349
BRD-A53576514-003-03-1
BRD-A53576514-048-06-9
BRN 1885151
Brocadisipal
Brocasipal (Salt/Mix)
BS-5930
BSPBio_000317
BSPBio_002141
C07935
CBDivE_006102
CCG-204966
CHEBI:7789
CHEMBL900
D08305
DB01173
Dimethyl-[2-(phenyl-o-tolyl-methoxy)-ethyl]-amine
dimethyl-2[alpha-(o-tolyl)benzyloxy]ethylamine
dimethyl({2-[(2-methylphenyl)(phenyl)methoxy]ethyl})amine
dimethyl{2-[(2-methylphenyl)phenylmethoxy]ethyl}amine
Disipal
DivK1c_000853
DTXSID3023396
EINECS 201-509-2
Ethanamine, N,N-dimethyl-2-((2-methylphenyl)phenylmethoxy)-
Ethanamine, N,N-dimethyl-2-[(2-methylphenyl)phenylmethoxy]-
Ethylamine, N,N-dimethyl-2-((o-methyl-.alpha.-phenylbenzyl)oxy)-
Ethylamine, N,N-dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)-
GTPL7251
HSDB 3139
IDI1_000853
Invagesic
KBio1_000853
KBio2_001525
KBio2_004093
KBio2_006661
KBio3_001641
KBioGR_000880
KBioSS_001525
L001253
Lopac0_000884
LS-68148
Lysantin
MCULE-7320950210
Mefenamine
Mephenamine (Salt/Mix)
Methyldiphenylhydramine
Mialgin (TN)
N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamin
N,N-dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine
N,N-Dimethyl-2-(o-methyl-alpha-phenylbenzyl)oxy)ethylamine
N,N-dimethyl-2-(phenyl(o-tolyl)methoxy)ethanamine
N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine
N,N-Dimethyl-2-[(2-methylphenyl)(phenyl)methoxy]ethanamine
N,N-Dimethyl-2-[(2-methylphenyl)(phenyl)methoxy]ethanamine #
N,N-Dimethyl-2-[(o-methyl-.alpha.-phenylbenzyl)oxy]ethylamine
N,N-Dimethyl-2-[(o-methyl-alpha-phenylbenzyl)oxy]ethylamine
N,N-dimethyl-2-{[(2-methylphenyl)(phenyl)methyl]oxy}ethanamine
NCGC00015771-03
NCGC00015771-05
NCGC00015771-06
NCGC00015771-07
NCGC00015771-09
NCGC00015771-10
NCGC00015771-12
NCGC00089814-02
NCGC00089814-03
NCGC00089814-05
NINDS_000853
Norflex Orphenadrine Citrate
Norgesic
o-Methyldiphenhydramine
o-Monomethyldiphenhydramine
Oprea1_476547
Orfenadrina
Orfenadrina [INN-Spanish]
ORP
Orphenadine
Orphenadinum
Orphenadrin
orphenadrine
Orphenadrine (INN)
Orphenadrine [INN:BAN]
Orphenadrinum
Orphenadrinum [INN-Latin]
Orphenate
Orphenedrine
Orphengesic
Phenyl-o-tolylmethyl dimethyaminoethyl ether
Phenyl-o-tolylmethyl dimethylaminoethyl ether
Prestwick0_000239
Prestwick1_000239
Prestwick2_000239
Prestwick3_000239
Q3292273
QVYRGXJJSLMXQH-UHFFFAOYSA-N
SBI-0050859.P004
SCHEMBL28727
Sodium Mefenamine
SPBio_001255
SPBio_002238
Spectrum_001045
Spectrum2_001038
Spectrum3_000531
Spectrum4_000460
Spectrum5_001036
ST50406606
WS 2434

US Patents and Regulatory Information for BIORPHEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eton Pharms BIORPHEN phenylephrine hydrochloride SOLUTION;INTRAVENOUS 212909-001 Oct 21, 2019 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Baxter
McKinsey
Dow
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.